Seres therapeutics inc.

Major-Pharmaceuticals

MCRB


200 Sidney Street
Cambridge , MA 02139

Executive/
Director

Price

  • Last Close
  • $ 0.82
    $ +0 0.49 %
    Dec 5, 2024
  • 52-Week High/Low
  • $3.63 - $0.58
  • YTD
  • -41.6%

  • Trading Volume
  • 28,584
  • Market Cap Full
  • $ 106M
  • Shares Outstanding
  • 129.3M
    Oct 30, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - -24.3% 13.8% -27.6% 52% -5% -16% -14.5% 1.3% -44.7%
Q2 -19.3% 9.4% 0.3% 24.5% -56% 4% 15.8% -51.8% -15.5% -0.5%
Q3 -28.6% -57.7% 42% -11.1% 35.7% 8% -70.8% 87.2% -50.3% -
Q4 18.4% -19.5% -17.6% -37.7% -12.7% -13.5% 19.7% -12.8% -34.9% -
J F M A M J J A S O N D
2024 -19.3% 0.9% -32.1% -1.4% - - - - - - - -
2023 -2.3% -7.7% 12.3% -14% 1.5% -3.2% 0.4% -28.3% -31% -35.7% -32% 34.6%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%-72%2%-55%-22%596%-66%-33%-75%-42%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - 0.50 0.63 -0.69 -0.59 -0.28 -0.39 -0.61 -0.57
Q2 - 0.70 0.69 -0.68 -0.24 -0.28 -0.53 -0.7 0.36
Q3 0.38 0.46 0.17 -0.54 -0.23 -0.36 0.72 -0.49 -0.37
Q4 0.41 0.63 0.71 -0.52 -0.18 -0.2 -0.52 -0.51 -
A 0.8 2.3 2.2 -2.4 -1.2 -1.1 -0.7 -2.3 -0.58

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 41 71.1 91.5 92 126.1
Jun 40.7 41.1 72.6 91.6 92.2 127.9
Sep 40.8 69.9 76.3 91.7 124.1 128.2
Dec 40.9 70 91.2 91.8 124.6 129.3

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.2 4.4 0.5 1.7 1
Total Asset Turnover - 0.4 0.1 0.3 0.2
Leverage
Debt Ratio 0.3 0.1 0.1 0.3 0.1
Debt – Equity Ratio 4.6 0.2 0.1 -0.5 -0.2
Interest Coverage -61.5 -32 -88 36 100
Equity multiplier 3.9 0.3 0.4 -0.4 -0.6